Sponsor:
Grossman, Michael, D.P.M.
Code:
NCT01712295
Conditions
Warts
Eligibility Criteria
Sex: All
Age: 12 - 70+
Healthy Volunteers: Not accepted
Interventions
17% Salicylate with ethyl pyruvate
Salicylates
Brief summary:
Conditions
Warts
Study ID
NCT01712295
Start date
Nov, 2011
Status verified date
Oct, 2012
Completion date
Mar, 2014
Anticipated
Primary completion date
Dec, 2013
Anticipated
Eligibility Criteria
Sex: All
Age: 12 - 70+
Healthy Volunteers: Not accepted
Enrollment
100 participants
Anticipated
Allocation
Randomized
Intervention Model
Parallel Assignment
Primary purpose
Treatment
Arms
experimental: 17% Salicylate with Ethyl Pyruvate
active comparator: 17% salicylate
Interventions
17% Salicylate with ethyl pyruvate
Salicylates
Primary outcome measure
Central contacts
Locations
Main Line Foot and Ankle Center
Recruiting
Ardmore, Pennsylvania, United States, 19003
Contacts
Principal Investigator:
Michael R Grossman, DPM
Sponsor
Grossman, Michael, D.P.M.
Last update posted
Oct 23, 2012
Last verified
Oct, 2012
Keywords
Trial information was received from ClinicalTrials.gov and was last updated on 2026-09-09. This information was provided to ClinicalTrials.gov by Grossman, Michael, D.P.M. on 2012-10-23.